Evidence map›Paper›PMID 38025074›Full record

ReviewFrontiers in chemistry2023

Nanotechnology for brain tumor imaging and therapy based on π-conjugated materials: state-of-the-art advances and prospects.

Wenshe Sun, Congxiao Wang, Chuan Tian, Xueda Li, Xiaokun Hu, Shifeng Liu

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Wenshe Sun *Department of Interventional Medical Center, Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
Congxiao Wang *Department of Interventional Medical Center, Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
Chuan TianDepartment of Interventional Medical Center, Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
Xueda LiDepartment of Interventional Medical Center, Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
Xiaokun HuDepartment of Interventional Medical Center, Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
Shifeng LiuDepartment of Interventional Medical Center, Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In contemporary biomedical research, the development of nanotechnology has brought forth numerous possibilities for brain tumor imaging and therapy. Among these, π-conjugated materials have garnered significant attention as a special class of nanomaterials in brain tumor-related studies. With their excellent optical and electronic properties, π-conjugated materials can be tailored in structure and nature to facilitate applications in multimodal imaging, nano-drug delivery, photothermal therapy, and other related fields. This review focuses on presenting the cutting-edge advances and application prospects of π-conjugated materials in brain tumor imaging and therapeutic nanotechnology.

Indexed as

brain tumorfluorescence imagingmolecular designphotodynamic therapyphotothermal therapyπ-conjugated materials

Identifiers

PMID38025074
PMCPMC10663370

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.